Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RATE-AF: Digoxin vs Beta-blockers in Permanent AF
NCT02391337Phase 4Completed
- Sponsor
- University of Birmingham
- Start
- Dec 2016
- Primary completion
- Apr 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of digoxin in Atrial fibrillation (AFib), sponsored by University of Birmingham. Started Dec 2016; status: completed.
02
Drugs
digoxin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02391337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02391337.